BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17986822)

  • 1. Genetic defects of the growth-hormone-IGF axis associated with growth hormone insensitivity.
    Woods K
    Endocr Dev; 2007; 11():6-15. PubMed ID: 17986822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical defects resulting in growth hormone insensitivity.
    Wit JM; de Luca F
    Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
    Rosenbloom AL
    Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of insulin-like growth factor deficiency.
    Wit JM; Oostdijk W; Losekoot M
    Endocr Dev; 2012; 23():30-41. PubMed ID: 23182818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT5B deficiency: Impacts on human growth and immunity.
    Hwa V
    Growth Horm IGF Res; 2016 Jun; 28():16-20. PubMed ID: 26703237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT5b deficiency: lessons from STAT5b gene mutations.
    Hwa V; Nadeau K; Wit JM; Rosenfeld RG
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):61-75. PubMed ID: 21396575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic causes of growth hormone insensitivity beyond GHR.
    Hwa V; Fujimoto M; Zhu G; Gao W; Foley C; Kumbaji M; Rosenfeld RG
    Rev Endocr Metab Disord; 2021 Mar; 22(1):43-58. PubMed ID: 33029712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.
    Hwa V; Little B; Adiyaman P; Kofoed EM; Pratt KL; Ocal G; Berberoglu M; Rosenfeld RG
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4260-6. PubMed ID: 15827093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New molecular mechanisms of growth hormone insensitivity].
    Edouard T; Raynal P; Yart A; Conte-Auriol F; Salles JP; Tauber M
    Arch Pediatr; 2008 Feb; 15(2):179-88. PubMed ID: 18207712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
    Ramírez L; Sanguineti N; Scaglia P; Keselman A; Ballerini MG; Karabatas L; Landi E; Castro J; Domené S; Pennisi P; Jasper H; Rey RA; Vázquez M; Domené H; Bergadá I; Gutiérrez M
    Growth Horm IGF Res; 2020 Feb; 50():61-70. PubMed ID: 31902742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I in human growth: lessons from defects in the GH-IGF-I axis.
    Hwa V; Fang P; Derr MA; Fiegerlova E; Rosenfeld RG
    Nestle Nutr Inst Workshop Ser; 2013; 71():43-55. PubMed ID: 23502138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
    Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues on molecular diagnosis of GH signaling defects.
    Feigerlova E; Hwa V; Derr MA; Rosenfeld RG
    Endocr Dev; 2013; 24():118-27. PubMed ID: 23392100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.
    Fang P; Kofoed EM; Little BM; Wang X; Ross RJ; Frank SJ; Hwa V; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1526-34. PubMed ID: 16464942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
    Kemp SF
    BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells.
    Ooi GT; Hurst KR; Poy MN; Rechler MM; Boisclair YR
    Mol Endocrinol; 1998 May; 12(5):675-87. PubMed ID: 9605930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic disorders in the growth hormone - insulin-like growth factor-I axis.
    Walenkamp MJ; Wit JM
    Horm Res; 2006; 66(5):221-30. PubMed ID: 16917171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic disorders of GH action pathway.
    Domené HM; Fierro-Carrión G
    Growth Horm IGF Res; 2018 Feb; 38():19-23. PubMed ID: 29249625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypes, investigation and treatment of primary IGF-1 deficiency.
    Savage MO
    Endocr Dev; 2013; 24():138-49. PubMed ID: 23392102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.